ABSTRACT
INTRODUCTION
Hepatic involvement in schistosomiasis mansoni results from the host immune response to disseminated eggs that were laid in the portal venous system and become trapped in hepatic sinusoids. This is because the eggs reaching the liver are too large to reach the sinusoidal plexus and accumulate in presinusoidal venules within the portal triads, especially in the left lobe, producing granulomatous lesions that are followed by fibrosis (1) . Therefore, hepatic fibrosis is considered as the main morbid sequala of schistosomiasis mansoni, which participates portal hypertension and bleeding oesophageal varices (2) . Basement membranes (BMs) are thin sheets of specialized extracellular matrix (ECM) which lay beneath epithelial and endothelial cells and surround other cell types. Besides providing tissue boundaries and structural support, BMs influence cell proliferation, differentiation, and migration. These membranes are predominantly composed of laminins, type IV collagen, heparan sulphate proteoglycans, and entactin/nidogen (3) . Although fragments of BM components have been detected in biological fluids in association with various inflammatory diseases, it is unknown whether its components are active in the regulation of inflammation or not (4,5) . As regards to schistosomiasis mansoni, previous studies showed that the schistosomules elaborate an antiinflammatory and immunomodulatory factors which may help the parasite to evade the host immune response (6,7) . In addition, chronic schistosomiasis is associated with impaired cellmediated immune response (8) . The H 2 O 2 peroxidase system, which is the cornerstone of host defense and associated with inflammation, is activated in close contact with parasite eggs. Moreover, hepatocytes undergo oxidative stress in the entire organ, which induces decrease of the liver antioxidant defences and deposition of ECM (9) with subsequent liver derangement. Also, reports indicated that the redox cascade involved in maintenance of cell haemostasis, as well as in the parasitic protection against reactive oxygen species produced by the host is known to influence the pro-oxidant/antioxidant balance in both host and parasite with a final effects on LFTs (10) . As a result, portal hypertension, which is defined as a pathological increase in the pressure of the portal venous system, was increased.
One of the most common causes of portal hypertension is cirrhosis which may be due to basement membrane formation, including LP1 and collagens deposition. This type of hypertension may also be present in the absence of cirrhosis, a condition referred to as "noncirrhotic portal hypertension" which can be divided into prehepatic, intrahepatic (presinusoidal, sinusoidal, postsinusoidal and post-hepatic causes). Schistosomiasis is one of the presinusoidal causes of noncirrhotic portal hypertension (11-13) . Liver performs many essential functions for the body, including absorption of fat in the diet (14) . Total bile acids (TBA) are essential components in absorption of such fats. These acids are principally synthesized by the liver and are strongly correlated with the development of hepatic fibrosis and portal hypertension. These render them to be used as indicators of liver damage (15) . Cholesterol, derived from circulating lipoproteins or from de novo synthesis in the liver, is converted to bile acids through chemical modifications initiated by 7α-hydroxylation. After conjugation to taurine or glycine, bile acids are actively secreted from the hepatocytes, together with free cholesterol and phospholipids, and are retained in the gallbladder during fasting. In response to a meal, cholecystokinin is released from the gut, resulting in the release of concentrated bile to the duodenum, where the detergent bile acids promote the absorption of dietary fat. Passive uptake of some bile acids occurs along the small intestine, but the major fraction is taken up by active transport in the terminal ileum. Bile acids are then transported in the portal vein back to the liver, where they are actively taken up in hepatocytes and resecreted into bile, thereby completing their enterohepatic circulation (16) . Hepatic schistosomiasis induces a compensatory hypertrophy of the hepatic artery, with increased sinusoidal pressure resulting in alterations of hepatic function (17) . Also, there are few published papers dealing with hepatic regeneration in schistosomiasis inspite of the importance of that disease (18) . Therefore, researchers have been stimulated to identify antifibrotic therapies. However, the most effective therapy for treating hepatic fibrosis to date is still to remove the causative agent. Also, they have been stimulated to identify antifibrotic therapies and to develop non-invasive markers to assess liver fibrosis as one of the strategies to follow-up the fibrotic and the antifibrotic changes in the liver (19) . For these reasons, formation of basement membrane, as was reflected by the pepsin-resistant fragment LP1 and the levels of TBA were used to evaluate the treatment and the regenerative effects of PZQ on the liver in schistosomiasis.
SUBJECTS & METHODS
The present study involved 45 Schistosoma mansoni infested patients in addition to 15 healthy individuals with matched age and sex which were used as a control group. The patients were classified into 3 groups according to the severity of liver damage using Child Pugh's score. Group I contained 15 patients with simple intestinal bilharzial infestation, group II consisted of 15 bilharzially infested patients with Child A and group III contained 15 bilharzia infested patients but with Child B. The patients were treated with triple doses of PZQ (40 mg/kg body weight).
All subjects were subjected to full clinical assessment to exclude other parasitic infections. Neither the patients nor the control groups had evidence of any other diseases nor any being treated with drugs known to affect liver function tests, bile acids or the parameters of the blood picture. The biochemical examinations were performed before and after 6 months of the last treatment dose.
Schistosoma mansoni infestation was detected by positive stool analysis using the direct smear technique and Kato thick smear (20) , sigmoidoscopy and rectal snips were performed for the negative stool samples. Also, indirect haemagglutination assay was performed to confirm bilharzial infestation using Fumouza and prothrombin time was determined by using the DiaMed's kit (DiaMed, 1785 Cressier, Switzerland).
Statistical analysis
The results were analyzed using instate software, version 2.03 (Graphpad, USA). The probability level signifying the variable grades of statistical significance are indicated as follow: P < 0.05 , significant and P<0.001 is highly significant. Also, the linear regression analysis was used to describe the relationships between the studied parameters. For comparison of the investigated parameters before with after treatment paired student t "t" test was used. Paried student "t' test was used to compare the parameters before and after treatment. Table 1 showed the results of the laboratory, clinical, ultrasonographical and the endoscopical data of Schistosoma mansoni infested patients before PZQ's treatment. This table showed that, Schistosoma antibodies were positive in sera of all patients. Simultaneously, the laboratory data showed that Schistosoma ova in stool were increased with the severity of the liver damage. Clinically, the hepatomegally, splenomegally and the presence of ascites were increased with the increase in the severity of the disease.
RESULTS
In addition, the ultrasonographic data showed that, the diameters of the splenic and portal veins were increased from simple intestinal into those with child B. Moreover, the degree of liver periportal fibrosis was increased with the increase in the size of the spleen and the shrinkage in the liver. At the same time, the number and the degree of oesophageal varices were increased, especially in patients with child A and child B using upper gastrointestinal endoscopy. Table 2 showed that before PZQ's treatment, the mean serum levels of TBA, LP1, bilirubin and the activities of ALP as well as those of liver transaminases (ALT and AST) were significantly higher in sera of all Schistosoma mansoni infested patients compared with those of the control group (P< 0.05). On the other hand, the mean serum albumin level was significantly decreased compared with that of the normal control (P< 0.0001).The same table showed that, such treatment repaired many of the parameters of LFTs in addition to reduction in the mean serum levels of both LP1 and TBA compared with their values in the non-treated group (Table 2) .
When the patients were classified according to the Child classification, it was shown that these parameters were changed with the severity of the disease. The increase in mean levels of both LP1 and TBA and in the mean activity of ALP and the decrease in serum albumin mean levels and in the prothrombin activities were repaired after treatment, especially in the earlier stages of the disease (Tables 3  and 4 ). Table  5 showed that, haemoglobin was improved only in simple intestinal bilharziasis but the total leukocytic count was decreased in that group. Concerning eosinophillic count, it was increased compared with the known value of normal control (from zero -1.0) and dramatically decreased after PZQ's treatment, especially in simple intestinal Schistosomiasis. Also, the drug caused reduction in the total leukocytic count compared with those before treatment. . Therefore, the effects of PZQ on one of the basement membrane component (LP1) and TBA were evaluated in the present study. Schistosomiasis mansoni infestation could overload hepatic injury on the basis of an already pathological situation. Hepatic schistosomiasis induces a compensatory hypertrophy of the hepatic artery, with increased sinusoidal pressure resulting in alterations of hepatic function (17) . This is already the case in the present study, since the LFTs were disturbed after bilharzial infestation (Tables 2 -5 ). The disturbance in LFTs may be due to the entrapment of the bilharzia ova in hepatic tissues. Such entrapment causes inflammation around the ova, and therefore, activation of the lipocytes, hepatocytes and other collagen synthesizing cells (25) to increase their secretion of collagens and other components of extracellular matrix (ECM). The excessive secretion of ECM causes fibrous expansion and basement membrane formation with a subsequent liver damage. In the current study, the positive correlation between both LP1 and TBA individual levels with eosinophillic count confirms the above mechanism of fibrogenesis (Table 6) .
Smerdson et al. (28) showed that the increases in serum laminin levels are due to the formation of basement membranes in the hepatic sinusoids and may also be due to a lack of degradation of that protein by liver endothelial cells a mechanism which was supported by Arthur (29) who showed that, the increase in collagenolytic activity is a major mechanism of resolution of fibrosis. In addition, Zheng et al. (30) showed that the increase in serum laminin concentration has been related to hepatic fibrosis and liver dysfunction in both human and experimental studies. This is already the case in the present study, because LP1 was strongly correlated with the markers of LFTs (Table 6) .
David et al. (31) showed that human eosinophils can kill antibodycovered schistosomula. The killing mediated by eosinophils is associated with adherence of these cells and subsequent degranulation and release of the eosinophillic major basic protein onto the larvae. Therefore, the increase in the eosinophillic count in the blood of schistosomiasis, in the present study, may be one of the control mechanisms of the disease.
Silveira-Lemos et al. (32) studied the activation-related surface markers and the detection of tumor necrosis factor-α (TNF-α), IL-4 and IL-5 markers in peripheral blood eosinophils from chronic Schistosoma mansoni infested patients. They pointed out, even patients with periportal fibrosis (PPF) presenting minor increment in eosinophil activation displayed higher levels of cytokine-positive eosinophils. They added that, lymphocyte-derived IL-10 was positively correlated with eosinophils cytokines, a finding which confirms the involvement of immunoregulatory mechanism in controlling disease morbidity in human Schistosomiasis. The increase in basement membrane formation and bile acid levels before PZQ,s treatment confirm the role of eosinophillia in the pathogenesis of the disease.
Moreover, the inflammation can activate the immune system cells causing excessive consumption of oxygen, increase in the amount of free radicals and decreases in the liver antioxidants , defences. All these consequences render the hepatocytes to undergo oxidative stress in the entire organ causing their damages (33) . Also, reports indicated that the redox cascade involved in maintenance of cell haemostasis, as well as in the parasitic protection against reactive oxygen species produced by the host is known to influence the prooxidant|antioxidant balance in both host and parasite (10,33) . The final sequel of these events is a more increase in the deposition of ECM with subsequent liver derangement (9) . This may be another mechanism for liver fibrosis in schistosomiasis in this study.
Since hepatic schistosomiasis induces a compensatory hypertrophy of the hepatic artery with increased sinusoidal pressure resulting in alterations of hepatic function (17) , the improvement in the parameters of LFTs, the decrease in TBA and in LP1 mean levels after treatment with PZQ (Tables 2-5) confirm that of Zucoloto et al. (34) who showed that extensive schistosomal lesions do not hinder hepatic cell regeneration. Also, it confirms that of Friedenberg et al. (35) , who showed that the quantification of hepatic fibrosis is important to stage and follow up the progression of chronic liver diseases and that of Ebeid et al. (36) who found that PZQ can be effectively used to treat S. haematobium infestation. In addition, the results of the present study confirm that of Botros et al. (37) who showed that infection with S. haematobium became potent 73 days post infection (PI). Tissue egg load and worm fecundity were higher at 95 days and maximal at the 115 th post infection with an organ pattern comparable to that in schistosoma mansoni infection. They also added that, granuloma were similar to those of S. mansoni in the livers and urinary bladders and one hundred percent worm eradication was recorded with the higher dose of PZQ in animals treated 75 and 95 days post infection. This eradication may be the causative factors of LFTs improvement, the increase in the TBA levels and the reduction in the basement membrane formation with a resultant decrease in LP1 mean levels, in the present study. The elevation of LP1 levels during bilharzial infestation and the reduction of its levels after PZQ's treatment may confirm the role of LP1 in the regulation of inflammation. These confirm that of Adair-Kirk et al. (38) who suggested that exposure of cryptic BM motifs at sites of injury may be an important mechanism for inducing expression of cytokines, expression and release of proteases, and recruitment of inflammatory cells. Together, these processes would serve to initiate repair and remodeling of the matrix and restoration of tissue integrity. This explanation is based on the improvement of LFTs, reduction in TBA and LP1 levels after PZQ treatment. Also, one can consider PZQ as a successful treatment of schistosomiasis. This is because Arthur (29) indicated that, spontaneous resolution of liver fibrosis can occur after the successful treatment of the underlying disease or cessation of liver injury even if advanced fibrosis is present. Abdel-Aziz et al. (39) showed that, PZQ acts as schistosomicidal drug via its synergetic effect with the immune system through its effect on Th1 activation (elevation of IL-2 levels) in mice infested with S. mansoni. The synergetic effect of PZQ with the immune system was also suggesred by Gryseels et al.
(40) . Therefore, the status of the immune system must be taken into consideration during treatment of schistosomiasis with PZQ. In conclusion, PZQ is one of the drugs of choice to treat bilharziasis and both TBA and LP1 can be used together with the routine LFTs for monitoring and evaluation of the efficacy of response to such treatment. Also, the role of LP1 in the regulation of inflammation, in the initiation of the repair mechanisms and in remodelling of the matrix, and hence, restoration of tissue integrity must not be neglected. 
